HomeCancerLung

Lung

Lung

Modeling Examine Tasks Vitrakvi (Larotrectinib) to Prolong Life Expectancy in Sure Lung and Thyroid Cancers

Editor -
A latest research printed within the Journal of Managed Care & Specialty Pharmacy analyzed the long-term effectiveness of Vitrakvi (larotrectinib) in contrast with...
Lung

Revolution Medicines Declares Publication Demonstrating Sturdy Anti-Tumor Exercise of RAS(ON) Inhibitors in Preclinical Fashions of Refractory KRAS-Mutated Non-Small Cell Lung Most cancers

Editor -
Unique analysis printed in Most cancers Discovery reveals a RAS(ON) multi-selective inhibitor exhibited strong anti-tumor exercise alone or together with a RAS(ON) G12C-selective...
Lung

Revolution Medicines Declares Publication Demonstrating

Editor -
Unique analysis printed in Most cancers Discovery reveals a RAS(ON) multi-selective inhibitor exhibited strong anti-tumor exercise alone or together with a RAS(ON) G12C-selective...
Lung

Officers Share Replace on Section 2 Trial of IDE397 for MTAP-Deletion NSCLC, UC

Editor -
Officers Share Replace on Section 2 Trial of IDE397 for MTAP-Deletion NSCLC, UCJuly 11, 2024
Lung

IDEAYA’s MAT2A Inhibitor Scores in Section II for Urothelial and NSCLC

Editor -
1...464748...82Page 47 of 82

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.